Observational studyScientific reports2024

Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry.

Gonzaga Garay-Aramburu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.